TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| EBITDA (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $9.3B | +9.0% | 0.8% | 8.1% |
| EBITDA (TTM) | $9.3B |
|---|---|
| YoY | +9.0% |
| 5-year CAGR | 0.8% |
| 10-year CAGR | 8.1% |
EBITDA
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $8.8B | +3.6% |
| 2024 | $8.5B | +7.1% |
| 2023 | $7.9B | −15.5% |
| 2022 | $9.4B | −13.6% |
| 2021 | $10.9B | +28.5% |
| 2020 | $8.5B | +63.9% |
| 2019 | $5.2B | −14.7% |
| 2018 | $6.1B | +21.2% |
| 2017 | $5.0B | +18.4% |
| 2016 | $4.2B | +4.8% |
| 2015 | $4.0B | −3.9% |
| 2014 | $4.2B | +60.5% |
| 2013 | $2.6B | +5.8% |
| 2012 | $2.5B | +16.8% |
| 2011 | $2.1B | +9.5% |
| 2010 | $1.9B | +9.2% |
| 2009 | $1.8B | −12.7% |
| 2008 | $2.0B | +16.8% |
| 2007 | $1.7B | — |